Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ziyue LIAO"'
Autor:
Xiangyu Yang, Zhili Zeng, Ziyue Liao, Caiyu Zhu, Hongyang Wang, Haijuan Wu, Shu Cao, Weizheng Liang, Xiushen Li
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Purpose Proximal gastrectomy (PG) offers advantages over total gastrectomy (TG) in enhancing the postoperative nutritional status of patients with proximal gastric cancer (PGC), yet its effect on long-term quality of life is still debated. T
Externí odkaz:
https://doaj.org/article/d95bae47ec1a4152b9090c27602dc49d
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundThis study aimed to evaluate the efficacy and safety of sequential immune checkpoint inhibitors (ICIs) plus bevacizumab therapy after radiotherapy for portal vein tumour thrombosis (PVTT) in patients with hepatocellular carcinoma (HCC).Meth
Externí odkaz:
https://doaj.org/article/115c940f380748488a31493539da7a86
Publikováno v:
Current Oncology, Vol 30, Iss 1, Pp 1243-1254 (2023)
Background: Transarterial chemoembolization (TACE) combined with tyrosine kinase inhibitors (TKIs) may enhance the efficacy of treatment for hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT); however, it remains unclear. We aim to
Externí odkaz:
https://doaj.org/article/362f5fdede42400bb3e9e67f16767b0f
Publikováno v:
Diagnostics, Vol 13, Iss 7, p 1211 (2023)
The most common cause of hepatocellular carcinoma (HCC) is chronic hepatitis and cirrhosis. It is proposed that precancerous lesions of HCC include all stages of the disease, from dysplastic foci (DF), and dysplastic nodule (DN), to early HCC (eHCC)
Externí odkaz:
https://doaj.org/article/fdda915a69214d4cb12a7c624a3bd47c
Background: The aim of this study was to investigate the changes in some immune-related indicators after radiotherapy for portal vein tumor thrombosis (PVTT) in patients with hepatocellular carcinoma (HCC), to evaluate the efficacy and safety of sequ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17336b5dd3990eff22b53f8a65d86ffa
https://doi.org/10.21203/rs.3.rs-2604867/v1
https://doi.org/10.21203/rs.3.rs-2604867/v1
Autor:
Yang, Xiangyu1,2 (AUTHOR), Zeng, Zhili3,4,5 (AUTHOR), Liao, Ziyue2 (AUTHOR), Zhu, Caiyu2 (AUTHOR), Wang, Hongyang2 (AUTHOR), Wu, Haijuan2 (AUTHOR), Cao, Shu6 (AUTHOR) shucao@ahtcm.edu.cn, Liang, Weizheng7 (AUTHOR) jmbb1203@126.com, Li, Xiushen1,8 (AUTHOR) lixiushenzplby@163.com
Publikováno v:
BMC Cancer. 10/15/2024, Vol. 24 Issue 1, p1-12. 12p.
Autor:
Liao, Ziyue1 (AUTHOR) 2020120766@stu.cqmu.edu.cn, Tang, Cuiping1 (AUTHOR) tangcuiping117@stu.cqmu.edu.cn, Luo, Rui1 (AUTHOR) ruil@stu.cqmu.edu.cn, Gu, Xiling2 (AUTHOR) guxiling@cqmu.edu.cn, Zhou, Jun3 (AUTHOR) zhoujun@hospital.cqmu.edu.cn, Gao, Jian1 (AUTHOR) gaojian@cqmu.edu.cn
Publikováno v:
Diagnostics (2075-4418). Apr2023, Vol. 13 Issue 7, p1211. 15p.
Publikováno v:
Current Oncology. Jan2023, Vol. 30 Issue 1, p1243-1254. 12p. 1 Diagram, 1 Chart, 3 Graphs.
Publikováno v:
Clinical Oncology Week; 4/11/2023, p795-795, 1p
Publikováno v:
Cancer Weekly; 2/7/2023, p732-732, 1p